Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54.5M
-
Number of holders
-
346
-
Total 13F shares, excl. options
-
41M
-
Shares change
-
+1.15M
-
Total reported value, excl. options
-
$3.68B
-
Value change
-
+$69M
-
Put/Call ratio
-
1.09
-
Number of buys
-
195
-
Number of sells
-
-166
-
Price
-
$89.60
Significant Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q4 2020
413 filings reported holding EBS - Emergent BioSolutions Inc. - Common Stock as of Q4 2020.
Emergent BioSolutions Inc. - Common Stock (EBS) has 346 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41M shares
of 54.5M outstanding shares and own 75.31% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.28M shares), VANGUARD GROUP INC (4.79M shares), STATE STREET CORP (2.15M shares), EARNEST PARTNERS LLC (1.39M shares), MANUFACTURERS LIFE INSURANCE COMPANY, THE (1.08M shares), Invesco Ltd. (1.08M shares), DIMENSIONAL FUND ADVISORS LP (1.04M shares), JANUS HENDERSON GROUP PLC (944K shares), GOLDMAN SACHS GROUP INC (901K shares), and PRICE T ROWE ASSOCIATES INC /MD/ (872K shares).
This table shows the top 346 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.